Assignee
LEWIS AND CLARK PHARMACEUTICALS INC
US·3 granted patents·1 pending application·31 citations·filing 2013–2017
Top patents by PatentIndex Score
4 records- 0192US9067963B2N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2013·Granted Jun 30, 2015·30 cites·32 claims
- 0269US9822141B2N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2015·Granted Nov 21, 2017·1 cites·28 claims
- 0350US2019077824A1N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as a2a agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0440US9593118B2Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2016·Granted Mar 14, 2017·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when LEWIS AND CLARK PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →